DNOPY vs. DXCM
DNOPY (Dino Polska S.A) and DXCM (DexCom, Inc.) are both stocks. DNOPY operates in Grocery Stores (Consumer Defensive), while DXCM operates in Diagnostics & Research (Healthcare). Over the past 5 years, DNOPY returned 4.72%/yr vs -5.34%/yr for DXCM. At a 0.03 correlation, their price movements are largely independent.
Performance
DNOPY vs. DXCM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DNOPY achieves a -29.00% return, which is significantly lower than DXCM's 9.64% return.
DNOPY
- 1D
- -0.36%
- 1M
- -5.93%
- YTD
- -29.00%
- 6M
- -23.54%
- 1Y
- -43.63%
- 3Y*
- -10.01%
- 5Y*
- 4.72%
- 10Y*
- —
DXCM
- 1D
- -0.93%
- 1M
- 21.20%
- YTD
- 9.64%
- 6M
- 12.21%
- 1Y
- -16.15%
- 3Y*
- -15.95%
- 5Y*
- -5.34%
- 10Y*
- 15.73%
DNOPY vs. DXCM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
DNOPY Dino Polska S.A | -29.00% | 19.79% | -16.65% | 30.68% | 2.43% | 10.75% | 89.61% |
DXCM DexCom, Inc. | 9.64% | -14.66% | -37.33% | 9.58% | -15.64% | 45.23% | 10.30% |
Correlation
The correlation between DNOPY and DXCM is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.04 |
Correlation (All Time) Calculated using the full available price history since May 1, 2020 | 0.03 |
Fundamentals
DNOPY:
$8.09B
DXCM:
$28.64B
DNOPY:
$1.59
DXCM:
$2.31
DNOPY:
5.20
DXCM:
31.44
DNOPY:
0.29
DXCM:
0.75
DNOPY:
0.23
DXCM:
6.07
DNOPY:
0.90
DXCM:
9.69
DNOPY:
$34.60B
DXCM:
$4.82B
DNOPY:
$8.12B
DXCM:
$2.96B
DNOPY:
$2.57B
DXCM:
$1.37B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DNOPY vs. DXCM — Risk / Return Rank
DNOPY
DXCM
DNOPY vs. DXCM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Dino Polska S.A (DNOPY) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DNOPY | DXCM | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -1.00 | -0.40 | -0.60 |
Sortino ratioReturn per unit of downside risk | -1.42 | -0.31 | -1.11 |
Omega ratioGain probability vs. loss probability | 0.82 | 0.96 | -0.14 |
Calmar ratioReturn relative to maximum drawdown | -0.91 | -0.42 | -0.49 |
Martin ratioReturn relative to average drawdown | -1.69 | -0.72 | -0.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| DNOPY | DXCM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.00 | -0.40 | -0.60 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.08 | -0.11 | +0.20 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.33 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 0.30 | -0.09 |
Drawdowns
DNOPY vs. DXCM - Drawdown Comparison
The maximum DNOPY drawdown since its inception was -48.35%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for DNOPY and DXCM.
Loading charts...
Drawdown Indicators
| DNOPY | DXCM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.35% | -94.61% | +46.26% |
Max Drawdown (1Y)Largest decline over 1 year | -48.35% | -38.75% | -9.60% |
Max Drawdown (3Y)Largest decline over 3 years | -48.35% | -60.95% | +12.60% |
Max Drawdown (5Y)Largest decline over 5 years | -48.35% | -66.32% | +17.97% |
Max Drawdown (10Y)Largest decline over 10 years | — | -66.32% | — |
Current DrawdownCurrent decline from peak | -45.58% | -55.31% | +9.73% |
Average DrawdownAverage peak-to-trough decline | -14.32% | -35.99% | +21.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.82% | 22.63% | +3.19% |
Volatility
DNOPY vs. DXCM - Volatility Comparison
The current volatility for Dino Polska S.A (DNOPY) is 11.25%, while DexCom, Inc. (DXCM) has a volatility of 13.22%. This indicates that DNOPY experiences smaller price fluctuations and is considered to be less risky than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DNOPY | DXCM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.25% | 13.22% | -1.97% |
Volatility (6M)Calculated over the trailing 6-month period | 37.09% | 24.61% | +12.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.68% | 40.26% | +3.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.30% | 46.91% | +11.39% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 59.80% | 48.43% | +11.37% |
Dividends
DNOPY vs. DXCM - Dividend Comparison
Neither DNOPY nor DXCM has paid dividends to shareholders.
Financials
DNOPY vs. DXCM - Financials Comparison
This section allows you to compare key financial metrics between Dino Polska S.A and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DNOPY vs. DXCM - Profitability Comparison
DNOPY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dino Polska S.A reported a gross profit of 2.02B and revenue of 8.44B. Therefore, the gross margin over that period was 24.0%.
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a gross profit of 750.30M and revenue of 1.19B. Therefore, the gross margin over that period was 63.0%.
DNOPY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dino Polska S.A reported an operating income of 419.22M and revenue of 8.44B, resulting in an operating margin of 5.0%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported an operating income of 255.30M and revenue of 1.19B, resulting in an operating margin of 21.4%.
DNOPY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dino Polska S.A reported a net income of 315.98M and revenue of 8.44B, resulting in a net margin of 3.7%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a net income of 199.50M and revenue of 1.19B, resulting in a net margin of 16.7%.
Frequently Asked Questions
DNOPY and DXCM have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DXCM has higher volatility (13.22%) compared to DNOPY (11.25%). In terms of maximum drawdown, DNOPY dropped -48.35% vs DXCM's -94.61%.
DXCM currently has the higher Sharpe Ratio (-0.40 vs -1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DNOPY and DXCM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer